A syringe filled with COVID-19 vaccine at North Suburban Medical Center in Thornton, Dec. 17, 2020.
Since the beginning of the pandemic, medical residents at the CU School of Medicine have been working with COVID-19 patients. As the hospitals they work at started to get Pfizer vaccines for frontline health care workers this month, residents were excited and relieved. But, in the first week of vaccine distribution they said they were treated as less of a priority than other medical professionals working with COVID-19 patients.
“It really felt like a willful disregard for our health and wellbeing,” said a senior resident who works at both Denver Health and UCHealth. “It felt like we were forgotten that no one had even considered to include 1,200 members of the health-care workforce in this plan to vaccinate people in the first round of vaccinations.”
Startup gets Army funding to test wearable monitor for early Covid-19 detection
Remote monitoring startup BioIntelliSense and Royal Phillips received $2.8 million to test BioIntelliSense’s device for the early detection of Covid-19 symptoms. The startup received FDA clearance for its small, adhesive monitoring device last year.
Shares1
BioIntelliSense makes small, adhesive sensors that can monitor a patient’s vital signs. Photo credit: BioIntelliSense
Remote-monitoring startup BioIntelliSense received funding from the U.S. Army Medical Research and Development Command (USAMRDC) to see if its wearable sensor “sticker” could be used to detect Covid-19 symptoms early. The Golden, Colo.-based startup, and Royal Philips (NYSE: PHG), received a $2.8 million award to use wearable to identify Covid-19 cases before symptoms appear.
News Category Global Banking & Finance Reviews
Philips, BioIntelliSense and University of Colorado receive U.S. Department of Defense funding for early COVID-19 detection
December 22, 2020
Cambridge, MA –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and
BioIntelliSense, Inc. [1], a continuous health monitoring and clinical intelligence company, today announced they have been selected by the U.S. Army Medical Research and Development Command (USAMRDC) to receive nearly USD 2.8 million from the U.S. Department of Defense (DoD) through a Medical Technology Enterprise Consortium (MTEC) award to validate BioIntelliSense’s FDA-cleared BioSticker device for the early detection of COVID-19 symptoms. The goal of the award is to accelerate the use of wearable diagnostics for the benefit of military and public health through the early identification and containment of pre-symptomatic COVID-19 cases.
Proper hand hygiene important to reduce COVID-19 transmission, protect skin barrier ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS
You ve successfully added to your alerts. You will receive an email when new content is published.
Back to Healio
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Back to Healio
Proper hand hygiene is essential to reduce COVID-19 transmission and preserve skin barrier integrity, according to a review published in
Email (required) (will not be published)
Due to incidents of abuse and harassment that have occurred in the past, JBHE will not publish telephone numbers or email addresses of individuals in this space. If you want to contact someone in a particular article, we suggest you contact them directly not in an open forum.
Which statement best reflects your view on reforming the Supreme Court?
Leave it alone.
Justices should have a 10-year term limit.
To ensure more moderate justices, a super majority of 60 senators should be required to confirm a justice to the court.